SAS Institute, Inc. ("SAS") is a privately held American software company headquartered at 100 SAS Campus Drive, Cary, North Carolina. It was incorporated in 1976 by Jim Goodnight, John Sall, Tony Barr, and Jane Helwig, growing out of a statistical-analysis software project at North Carolina State University. Co-founders Goodnight (CEO) and Sall each still hold roughly two-thirds and one-third of the equity, respectively; the company has never taken outside capital or gone public. SAS reports annual revenue above $3 billion (Forbes cites more than $3 billion for 2024) and approximately 11,000 employees, per its 50th-anniversary press materials.
SAS develops and licenses analytics, AI, and business-intelligence software. Its core offerings include the long-standing Base SAS statistical programming system and its module library; the SAS Viya cloud-native data and AI platform (with components such as Viya Workbench, Viya Copilot, and App Factory); SAS Data Maker for synthetic data; and industry solutions spanning fraud and anti-money-laundering detection, risk and regulatory compliance, health and life-sciences analytics, customer intelligence (SAS Customer Intelligence 360), and IoT analytics. It also operates the JMP Statistical Discovery subsidiary, which sells JMP, JMP Pro, JMP Clinical, and JMP Genomics.
On patent litigation, SAS is predominantly an operating company on the defensive. Of its three tracked matters, one is as a defendant — ComplementSoft, LLC v. SAS Institute, Inc. (N.D. Ill., filed Sept. 14, 2012), a patent-infringement suit brought by patent owner ComplementSoft over a data-flow-representation software patent. The two remaining matters are SAS's own follow-on challenges: the inter partes review SAS Institute, Inc. v. ComplementSoft, LLC (PTAB, 2013) and the appeal SAS Institute Inc. v. Andrei Iancu, Director, USPTO (Supreme Court, 2017). No tracked cases appear in the Eastern District of Texas, and the docket shows no pattern of SAS asserting patents offensively.
The most prominent matter is SAS Institute Inc. v. Iancu, in which the Supreme Court (decided April 24, 2018) held that 35 U.S.C. § 318(a) requires the PTAB to issue a final written decision on every claim challenged in an IPR petition, rejecting the Board's "partial institution" practice. The case originated when SAS challenged all 16 claims of ComplementSoft's patent and the Board instituted review on only a subset.